1. Home
  2. PTGX vs KNTK Comparison

PTGX vs KNTK Comparison

Compare PTGX & KNTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • KNTK
  • Stock Information
  • Founded
  • PTGX 2006
  • KNTK 2017
  • Country
  • PTGX United States
  • KNTK United States
  • Employees
  • PTGX N/A
  • KNTK N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • KNTK Natural Gas Distribution
  • Sector
  • PTGX Health Care
  • KNTK Utilities
  • Exchange
  • PTGX Nasdaq
  • KNTK Nasdaq
  • Market Cap
  • PTGX 3.3B
  • KNTK 2.7B
  • IPO Year
  • PTGX 2016
  • KNTK N/A
  • Fundamental
  • Price
  • PTGX $53.00
  • KNTK $41.42
  • Analyst Decision
  • PTGX Strong Buy
  • KNTK Buy
  • Analyst Count
  • PTGX 9
  • KNTK 9
  • Target Price
  • PTGX $67.11
  • KNTK $56.56
  • AVG Volume (30 Days)
  • PTGX 949.2K
  • KNTK 1.2M
  • Earning Date
  • PTGX 08-05-2025
  • KNTK 08-06-2025
  • Dividend Yield
  • PTGX N/A
  • KNTK 7.53%
  • EPS Growth
  • PTGX N/A
  • KNTK N/A
  • EPS
  • PTGX 0.86
  • KNTK 0.94
  • Revenue
  • PTGX $207,801,000.00
  • KNTK $1,584,798,000.00
  • Revenue This Year
  • PTGX N/A
  • KNTK $15.38
  • Revenue Next Year
  • PTGX $53.09
  • KNTK $34.42
  • P/E Ratio
  • PTGX $61.45
  • KNTK $43.90
  • Revenue Growth
  • PTGX N/A
  • KNTK 20.36
  • 52 Week Low
  • PTGX $32.50
  • KNTK $37.85
  • 52 Week High
  • PTGX $60.60
  • KNTK $67.60
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 53.99
  • KNTK 39.01
  • Support Level
  • PTGX $49.38
  • KNTK $42.06
  • Resistance Level
  • PTGX $51.51
  • KNTK $43.15
  • Average True Range (ATR)
  • PTGX 2.02
  • KNTK 1.29
  • MACD
  • PTGX -0.39
  • KNTK -0.17
  • Stochastic Oscillator
  • PTGX 46.09
  • KNTK 9.22

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About KNTK Kinetik Holdings Inc.

Kinetik Holdings Inc is a midstream operator that provides gathering and processing services to gas and oil producers as well as pipeline transportation. In addition to directly operating pipelines, Kinetik also holds ownership stakes in several pipelines. The company operates in two reportable segments which include The Midstream Logistics segment operates under three service offerings, 1) gas gathering and processing, 2) crude oil gathering, stabilization, and storage services, and 3) produced water gathering and disposal. The Pipeline Transportation segment consists of three EMI pipelines originating in the Permian Basin with various access points to the U.S. Gulf Coast, Kinetik NGL Pipelines, and Delaware Link Pipeline.

Share on Social Networks: